{
  "id": 19620113,
  "title": "Pharma: Bayer receives green light for stroke medication",
  "url": "https://urgent.news/2026/11/12/pharma-bayer-erhalt-grunes-licht-fur-schlaganfall-medikament",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-12T07:35:00.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/pharma-was-die-us-zulassung-des-schlaganfallmittels-fuer-bayer-bedeutet/100266747.html"
  },
  "original_language": "de",
  "account": null,
  "summary": "For the pharmaceutical division, US approval is crucial: its bestseller Xarelto is losing sales. Asundexian is intended to fill the gap - especially in the US, where Bayer is growing the fastest.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}